SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Lonza sets CHF7.5bn 2022 sales target citing pharma drivers

Lonza Group AG has predicted it will generate annual revenue of CHF7.5bn by 2022, citing recent acquisition Capsugel and its new Visp-based Ibex manufacturing service as drivers.

New drugs now: UK provides funds for smaller drug makers

The UK government has announced £6m ($7.8m) funding for small and medium sized enterprises (SMEs) to speed up access to new medicines.

Recipharm installs dedicated production line for prostate cancer depot

Recipharm has installed a dedicated production line to make prostate cancer drug Liproca Depot for Swedish pharma firm LIDDS AB.

News in brief

Unichem outlines manufacturing plan for generic Hyzaar

Unichem Laboratories Limited has confirmed it will make its generic version of Hyzaar for the US market at three plants in India.

STA to supply intermediate for Tesaro 's $117k-a-year cancer drug Zejula

Tesaro Inc has hired STA Pharmaceutical Co. Ltd to supply intermediates for its recently approved, $117k-a-year, ovarian cancer drug Zejula (niraparib).

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...